pha3thc pharmacy practice and therapeutics c (psychiatry and neurology)

PHARMACY PRACTICE AND THERAPEUTICS C (PSYCHIATRY AND NEUROLOGY)

PHA3THC

2020

Credit points: 15

Subject outline

This subject investigates the brain. Ultimately, behaviour is the outcome of cellular and molecular processes within the brain, and subtle changes in brain physiology will result in spectacular and often debilitating behavioural pathologies. Therapeutic intervention based on psychotropic drugs aims to restore or tweak brain physiology - while conceptually a sound approach, our understanding of how neurophysiology ultimately is expressed in behaviour, is limited. As a consequence, this subject will not provide you with answers, but aims to enable you to critically appraise therapeutic intervention. In addition, the pharmacy practice issues relating to neuropsychiatry will be addressed in a manner that highlights how psychotropic drugs can ameliorate the various disease states, and how they affect the overall condition of the patient.

SchoolMolecular Sciences

Credit points15

Subject Co-ordinatorChristine Kettle

Available to Study Abroad/Exchange StudentsYes

Subject year levelYear Level 3 - UG

Exchange StudentsNo

Available as ElectiveNo

Learning ActivitiesN/A

Capstone subjectNo

Subject particulars

Subject rules

Prerequisites PHA2THA and must be admitted in the Bachelor of Pharmacy Honours (SHPB)

Co-requisitesN/A

Incompatible subjectsN/A

Equivalent subjectsPHA3PGD

Quota Management StrategyN/A

Quota-conditions or rulesN/A

Special conditionsN/A

Minimum credit point requirementN/A

Assumed knowledgeN/A

Learning resources

Pharmacology

Resource TypeBook

Resource RequirementPrescribed

AuthorRang, HP et al.

Year2012

Edition/Volume7TH EDITION

PublisherCHURCHILL LIVINGSTONE, EDINBURGH

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Neurology, Psychotropic, Analgesic

Resource TypeBook

Resource RequirementRecommended

AuthorTherapeutic Guidelines Ltd

YearN/A

Edition/VolumeN/A

PublisherLATEST VERSION, THERAPEUTIC GUIDELINES LIMITED, NORTH MELBOURNE

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Essential Psychopharmacology

Resource TypeBook

Resource RequirementRecommended

AuthorStahl, SM

Year2008

Edition/Volume3RD EDITION

PublisherCAMBRIDGE UP

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Goodman & Gilman's Manual of Pharmacology and Therapeutics

Resource TypeBook

Resource RequirementRecommended

AuthorBrunton, L & Parker, K

Year2006

Edition/Volumesoft cover portable volume

PublisherMCGRAW-HILL

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Australian Medicines Handbook.

Resource TypeBook

Resource RequirementRecommended

AuthorRossi, R

Year2009

Edition/VolumeN/A

PublisherADELAIDE: AUSTRALIAN MEDICINES HANDBOOK PTY LTD.

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Career Ready

Career-focusedNo

Work-based learningNo

Self sourced or Uni sourcedN/A

Entire subject or partial subjectN/A

Total hours/days requiredN/A

Location of WBL activity (region)N/A

WBL addtional requirementsN/A

Graduate capabilities & intended learning outcomes

Graduate Capabilities

Intended Learning Outcomes

01. Explain the role of neurotransmitter systems in the operation of the central nervous system

02. Relate the relevant class of drugs to activity at the molecular level, specifically effect on relevant receptors and other regulatory molecules and processes.

03. Describe and explain the relationship between drug actions and therapeutic outcomes, specifically in the amelioration of clinical conditions related to the central nervous system.

04. Describe the absorption, elimination and metabolism of cardiovascular and respiratory drugs and relate this to clinical practice and how pharmacogenetics affects this.

05. Anticipate and rationalize interaction between drugs (including over-the-counter (OTC preparations)

06. Follow guidelines to critically assess drug use and disease states in a defined case study scenario.

07. Initiate appropriate procedures for mental health first aid

Subject options

Select to view your study options…

Bendigo, 2020, Semester 2, Day

Overview

Online enrolmentYes

Maximum enrolment sizeN/A

Enrolment informationN/A

Subject Instance Co-ordinatorChristine Kettle

Class requirements

LectureWeek: 31 - 43
Three 1.00 hour lecture per week on weekdays during the day from week 31 to week 43 and delivered via face-to-face.

PracticalWeek: 32 - 34
One 3.00 hours practical per week on weekdays during the day from week 32 to week 34 and delivered via face-to-face.

WorkShopWeek: 31 - 43
One 2.00 hours workshop per week on weekdays during the day from week 31 to week 43 and delivered via face-to-face.

Assessments

Assessment element	Comments	Category	Contribution	Hurdle	%	ILO*
2 oral presentations (1 group and 1 individual) (750 word equivalent total)	N/A	N/A	N/A	No	20	SILO2, SILO3, SILO4, SILO5, SILO6, SILO7
Case study (1000 word equivalent)	N/A	N/A	N/A	No	20	SILO1, SILO2, SILO3, SILO4, SILO5, SILO7
Online quiz and mental health activities (500 word equivalent)	N/A	N/A	N/A	No	10	SILO1, SILO2, SILO3, SILO5, SILO7
One 2-hour written examination	N/A	N/A	N/A	No	50	SILO1, SILO2, SILO4, SILO6, SILO7